Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Amlodipine Besylate,Celecoxib
Therapeutic Area : Neurology
Study Phase : Approved
Sponsor : Coeptis Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Agreement
Burke Therapeutics, LLC Signs Exclusive US Marketing and Supply Agreement
Details : Burke will market the fixed-dose combination drug, Consensi to lower blood pressure, and celecoxib for the management of the signs and symptoms of osteoarthritis.
Brand Name : Undisclosed
Molecule Type : Small molecule
Upfront Cash : Undisclosed
March 11, 2020
Lead Product(s) : Amlodipine Besylate,Celecoxib
Therapeutic Area : Neurology
Highest Development Status : Approved
Sponsor : Coeptis Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Agreement
LOOKING FOR A SUPPLIER?